Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Monitoring dietary therapy of patients with galactosemia due to
galactose-1-phosphate uridyltransferase deficiency or uridine
diphosphate (UDP) galactose-4-epimerase deficiency.
Galactose-1-phosphate (Gal-1-P) accumulates in the erythrocytes of
patients with a deficiency of galactose-1-phosphate uridyltransferase
(GALT: classic galactosemia and its variants) or uridine diphosphate
(UDP) galactose-4-epimerase. The clinical presentation of classic
galactosemia is characterized by failure to thrive, vomiting, liver
disease, cataracts, and developmental delay. These symptoms
develop in the newborn period once a lactose-containing diet
(e.g., human and cow's milk) is introduced (lactose is a disaccharide
that is metabolized to galactose and glucose). Galactosemia is
treated by restriction of galactose from the diet, which allows for fast
recovery from the acute symptoms and a good prognosis. The
concentration of Gal-1-P in erythrocytes is the most sensitive
index of dietary control.
Non-galactosemic: 5-49 ug/g of hemoglobin
Galactosemic on galactose restricted diet: 80-125 ug/g of hemoglobin
Galactosemic on unrestricted diet: >125 ug/g of hemoglobin
The concentration of Gal-1-P is provided along with reference
ranges for non galactosemic probands as well as galactosemic
patients. The goal of treatment of a galactosemic patient is to keep the
Gal-1-P levels below 125 ug/g of hemoglobin.
Not a screening test for galactosemia
1. Gitzelmann R: Estimation of Galactose-1-Phosphate in erythrocytes:
A rapid and simple enymatic method. Clin Chim Acta 1969;26:313-316
2. Elsas LJ: Galactosemia. GeneClinics: Medical
Genetics Knowledge Base, University of Washington, Seattle.
Retrieved1999 November 30. Available from URL:
http://www.geneclinics.org/profiles/galactosemia/
3. Holton JB, Walter JH, Tyfield LA: Galactosemia. In The Metabolic
and Molecular Bases of Inherited Disease. 8th edition. Edited by
CR Scriver, AL Beaudet, D Valle, et al. New York, McGraw-Hill,
2001, pp 1553-1587